| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000019881 |
| Receipt No. | R000022967 |
| Official scientific title of the study | Effect of alcohol-metabolizing stimulation by ingestion of supplement containing freshwater clam extractive: a randomized, double blind, placebo-controlled cross over study |
| Date of disclosure of the study information | 2015/11/20 |
| Last modified on | 2016/09/01 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Effect of alcohol-metabolizing stimulation by ingestion of supplement containing freshwater clam extractive: a randomized, double blind, placebo-controlled cross over study | |
| Title of the study (Brief title) | Effect of alcohol-metabolizing stimulation by ingestion of supplement containing freshwater clam extractive | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adult | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | This study aims to evaluate improvement effects of alcohol-metabolizing stimulation by ingestion of supplement containing freshwater clam extractive consecutively for 7 days on healthy adult. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | blood-alcohol content (before and after ingestion of supplement for 7 days, and just before and just after alcohol drinking) |
| Key secondary outcomes | calculation test (the morning after alcohol drinking), subjective evaluation (before and after ingestion of supplement for 7 days) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake test sample for 7 days, and take wash out period for 2 week, then intake placebo for 7 days. | |
| Interventions/Control_2 | Intake placebo for 7 days, and take wash out period for 2 week, then intake test sample for 7 days. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Male and female between 30 and 69 years of age
2. Subjects who are able to drink alcohol. |
|||
| Key exclusion criteria | 1. Subjects with food allergies
2. Subjects who are pregnant or lactating 3. Subjects who consume medicinal product which may influence the outcome of the study 4.Subjects who consume food which may influence the outcome of the study 5. Subjects who are judged as unsuitable for the study by the investigator for other reasons |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Masatomo Najima |
| Organization | Japan clinical trial association |
| Division name | N.A. |
| Address | 8F, 5-27-3 sendagaya, shibuyaku, Tokyo |
| TEL | 03-6457-4666 |
| info@yakujihou.org | |
| Public contact | |
| Name of contact person | Hirohisa Kojima |
| Organization | Japan clinical trial association |
| Division name | N.A. |
| Address | 8F, 5-27-3 sendagaya, shibuyaku, Tokyo |
| TEL | 03-6457-4666 |
| Homepage URL | |
| info@yakujihou.org | |
| Sponsor | |
| Institute | Japan clinical trial association |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Yawata Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022967 |